Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: A retrospective review and case–control study of 21 patients

…, M Harigai, R Koike, H Sugiyama… - Arthritis Care & …, 2009 - Wiley Online Library
Objective To establish proper management of Pneumocystis jiroveci pneumonia (PCP) in
rheumatoid arthritis (RA) patients treated with infliximab. PCP has been observed in 0.4% of …

Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19

M Sugiyama, N Kinoshita, S Ide, H Nomoto… - Gene, 2021 - Elsevier
COVID-19, a novel coronavirus-related illness, has spread worldwide. Patients with apparently
mild/moderate symptoms can suddenly develop severe pneumonia. Therefore, almost all …

[HTML][HTML] Inhaled GM-CSF for pulmonary alveolar proteinosis

…, M Oda, H Ishii, S Izumi, H Sugiyama… - … England Journal of …, 2019 - Mass Medical Soc
Background Pulmonary alveolar proteinosis is a disease characterized by abnormal
accumulation of surfactant in the alveoli. Most cases are autoimmune and are associated with an …

[HTML][HTML] The importance of bacterial and viral infections associated with adult asthma exacerbations in clinical practice

…, N Kobayashi, S Yamaguchi, S Nakae, H Sugiyama - PloS one, 2015 - journals.plos.org
Background Viral infection is one of the risk factors for asthma exacerbation. However, which
pathogens are related to asthma exacerbation in adults remains unclear. Objective The …

Sex‐associated differences between BMI and SARS‐CoV‐2 antibody titers following the BNT162b2 vaccine

…, M Konishi, M Ozeki, K Miyo, W Sugiura, H Sugiyama… - …, 2022 - Wiley Online Library
Objective This study investigated the sex‐associated difference in the impact of obesity on
antibody response to a COVID‐19 vaccine. Methods This study included 2,435 health care …

Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long‐term inhaled corticosteroid therapy

M Hojo, M Iikura, S Hirano, H Sugiyama… - …, 2012 - Wiley Online Library
Background and objective: The risk of pneumonia is increased among COPD patients using
inhaled corticosteroids (ICS). However, there is uncertainty regarding the association …

Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT. TB on active tuberculosis in Japan

…, M Hashimoto, M Iikura, S Izumi, H Sugiyama… - Journal of infection and …, 2018 - Elsevier
Background The QuantiFERON-TB Gold Plus (QFT-Plus) was introduced in 2015 as a new
generation of interferon-gamma release assays (IGRAs) designed to detect Mycobacterium …

COVID-19 and bronchial asthma: current perspectives

…, J Terada-Hirashima, H Sugiyama - Global Health & Medicine, 2021 - jstage.jst.go.jp
Angiotensin converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2),
two receptors on the cell membrane of bronchial epithelial cells, are indispensable for …

Call for international cooperation and collaboration to effectively tackle the COVID-19 pandemic

N Kokudo, H Sugiyama - Global Health & Medicine, 2020 - jstage.jst.go.jp
The world is facing an unprecedented challenge in every place that is affected by the
spreading COVID-19 pandemic. With China recording fewer and fewer cases, Europe and the …

Diagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR

…, M Hojo, T Miyoshi-Akiyama, H Sugiyama - Infectious …, 2021 - Taylor & Francis
Background The current gold standard in coronavirus disease (COVID-19) diagnostics is
the real-time reverse transcription–polymerase chain reaction (RT-PCR) assay for detecting …